Intrinsa

Active Substance: testosterone
Common Name: testosterone
ATC Code: G03BA03
Marketing Authorisation Holder: Warner Chilcott UK Ltd.
Active Substance: testosterone
Status: Withdrawn
Authorisation Date: 2006-07-28
Therapeutic Area: Sexual Dysfunctions, Psychological
Pharmacotherapeutic Group: Sex hormones and modulators of the genital system

Therapeutic Indication

Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.

The marketing authorisation for Intrinsa has been withdrawn at the request of the marketing-authorisation holder.

 

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)